In the ongoing study, the possibility of mutations in the binding region (Pro–Glu–Leu–Pro–Lys; PELPK) of the CEACAM5 gene in patients with AA or colorectal adenocarcinoma is being explored in a comparative genetic association analysis. This evidence concerns the gene CEACAM5 and colorectal adenocarcinoma.